pharmaceutical investing La Jolla Pharmaceutical Company Gets European Commission Approval for GIAPREZA
pharmaceutical investing Theratechnologies Receives Positive Recommendation From the CHMP for Trogarzo® in the European Union
pharmaceutical investing Dova Pharmaceuticals Announces European Union Marketing Authorization for DOPTELET®
pharmaceutical investing Tetraphase Pharmaceuticals Announces Adoption of Commission Decision Granting Marketing Authorisation Approval in the European Union for XERAVA
pharmaceutical investing Yescarta (Axicabtagene Ciloleucel) Receives European Marketing Authorization for the Treatment of Relapsed or Refractory DLBCL and PMBCL
pharmaceutical investing Eisai and Merck Announce European Commission Grants Marketing Authorization for LENVIMA (lenvatinib) as First-Line Treatment in Adults with Advanced or Unresectable Hepatocellular Carcinoma
